Kodiak Sciences
KOD
97.17
-0.73
-0.75%
Kodiak Sciences
US · KOD
#1934 by market cap
Listed 2018
97.17
-0.73
-0.75%
Periodic snapshot; not a real-time feed.
· 2026-11-20 19:57
About Kodiak Sciences
Kodiak Sciences, Inc. is a clinical-stage biopharmaceutical company, which engages in the research, development, and commercialization of therapeutics for retinal diseases. Its product pipeline includes KSI-301 for wet AMD, KSI-301 for diabetic eye disease, KSI-501 for DME and uveitis, KSI-201 for resistant wet AMD, and KSI-401 for dry AMD. The company was founded by Stephen A. Charles and Victor Perlroth in 2009 and is headquartered in Palo Alto, CA.
- Founded
- 2009
- CEO
- Dr. Victor Perlroth, M.D.
- Employees
- 124
- Headquarters
- Palo Alto, California, United States of America
- Fiscal year end
- 12-31
- Website
- kodiak.com
Company profile
- Exchange
- US
- Symbol
- KOD
- Market-cap rank
- #1934
- Listing date
- 2018-10-04
- Market cap
- 6.35B
- Float cap
- 3.82B
- Shares out
- 65.40M
- Float shares
- 39.27M
Sectors & themes
Quote time 2026-11-20 19:57:11 · For reference only, not investment advice and not tailored to your situation.
Kodiak Sciences discussion 0 comments